Eosinophilic esophagitis
Board exam relevance: in 5 of more than 100 exam reports · rank 69- Synonyms
- EoE, allergic oesophagitis, asthma of the oesophagus, food impaction
- Specialty
- Internal medicine · Gastroenterology
- Images
- Endoscopy 2 · Histology 1
- Last updated
- 10/2026 · Dr. Pascal Bafteh
Contents
Images (3)
Endoscopy
Endoscopy
HistologyDefinition
Eosinophilic esophagitis (EoE) is a chronic immune-mediated disease of the esophagus with eosinophil-predominant inflammation. It can cause reflux-like symptoms, dysphagia and food impaction. The diagnosis rests on the combination of clinical, endoscopic and histological findings.
Occurrence & epidemiology
EoE was only described as a distinct entity in 1993/1994; incidence and prevalence have increased since then. A meta-analysis found an incidence of 6.6 per 100,000 person-years in children and 7.7 in adults, and a prevalence of 34 per 100,000 children and 42.2 per 100,000 adults. Men are affected about three times as often. More than 65 % of cases occur in childhood, with another peak between 30 and 44 years. The disease is more common in Europe and North America than in Eastern countries.
Aetiopathogenesis
- Immune reaction to food antigens in genetically susceptible individuals; environmental allergens probably also play a role.
- Most common triggers: milk, wheat, soy, eggs, peanuts and tree nuts, and fish and shellfish.
- Type 2 inflammation: Th2 lymphocytes and cytokines such as interleukin-4, -5 and -13; interleukin-13 promotes the production of eotaxin-3, which attracts eosinophils.
- Barrier dysfunction: reduced filaggrin and desmoglein-1 make it easier for allergens to penetrate.
- Genetic risk variants: e.g. in CCL26 (eotaxin-3), TSLP, filaggrin, desmoglein-1, STAT6 and CAPN14.
- Remodelling: persistent inflammation leads to fibrosis and tissue remodelling with narrowing and strictures.
Clinical features
- Infants and young children: vomiting, food refusal, dysphagia, loss of weight, abdominal or chest pain, less often failure to thrive.
- School-age children and adolescents: dysphagia and food impaction, especially with coarse food; also chest and abdominal pain, vomiting, regurgitation.
- Adults: dysphagia for solids and food impaction as the most common symptoms, as well as heartburn.
- Coexisting atopy: frequently asthma, atopic dermatitis or allergic rhinitis.
- Course: chronic; persistent inflammation can lead to narrowing and strictures of the esophagus.
Histology
The histological diagnosis is established with at least 15 eosinophils per high-power field (HPF). Because eosinophilic infiltrates are patchy, biopsies are taken from the upper, middle and lower thirds of the esophagus.
Diagnosis
- Suspicion: typically dysphagia for solids with a history of atopy; also with reflux symptoms that do not improve with acid-suppressing drugs, and in adults with food impaction or non-cardiac chest pain.
- Endoscopy: longitudinal furrows, concentric rings, whitish exudates, strictures, a narrowed lumen, superficial tears on passing the endoscope, loss of vascular markings. The EREFS score summarises rings, furrows, exudates and edema plus additional findings. In 10–25 % the esophagus looks normal at endoscopy – biopsies are therefore always taken.
- Biopsies: 6 to 9 samples from different levels markedly increase sensitivity; samples from the proximal/middle and distal esophagus are processed separately, as reflux disease can also cause eosinophilic infiltrates.
- Barium swallow: may show stacked rings, longitudinal furrows, a narrow calibre or strictures.
- Impedance planimetry: occasionally used to detect subtle strictures.
- Food allergy testing: of little benefit, as EoE is not fully IgE-mediated.
Treatment principles
- Treatment rests on three pillars: drugs, elimination diet and endoscopic dilatation.
- Drug therapy uses high-dose proton pump inhibitors or topically acting swallowed glucocorticoids, with biologics in refractory disease; alternatively, a stepwise empirical elimination diet can identify triggers.
- Symptomatic strictures are dilated endoscopically; as the disease is chronic, maintenance therapy with histological monitoring is usually required.
Specific treatment regimens with drugs and doses are covered in the InnereFuchs app.
Keep learning in the app
Further reading (open access)
Cross-references
More topics: Gastroenterology
- Ulcerative colitis
- Gastritis (type A, B and C)
- Peptic ulcer disease
- Crohn's disease
- Familial adenomatous polyposis (FAP)
- Gastro-esophageal reflux disease (GERD)
- Helicobacter pylori infection
- Hiatus hernia
- Bowel obstruction (ileus)
- Infectious gastroenteritis and travelers' diarrhea
- Ischemic colitis
- Colorectal adenomas (polyps)
Keep learning
Keep learning with flashcards, exam questions and spot diagnoses in the InnereFuchs app – free, in your browser or as an app.
Related pages: Ulcerative colitis · Gastritis (type A, B and C) · Peptic ulcer disease
Note: Learning content for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.